Achiko AG (ACHKF) Research

Achiko AG, established in 2018 and based in Zurich, Switzerland, focuses on pioneering diagnostic technologies for both Indonesian and international markets. Its flagship innovation is AptameX, a rapid diagnostic test that identifies the SARS-CoV-2 virus by utilizing DNA aptamers, distinguishing it from traditional antigen-based methods. The company also offers Teman Sehat, a mobile application serving as a check-in and digital health passport. Additionally, under the Mimopay brand, Achiko AG provides secure payment processing, enabling game publishers and application developers to accept diverse payment methods for digital content and merchandise. The firm is also involved in the development of game software.

Market snapshot

Symbol
ACHKF
Price
$0.00
Day change
0.00%
Market cap
$377.4K
P/E ratio
-0.04x
52-week range
0.0026-0.0026
Sector
Healthcare
Industry
Medical - Healthcare Information Services

Peer companies

  • Alseres Pharmaceuticals, Inc. (ALSE)
  • Aquarius Surgical Technologies Inc. (AQQRF)
  • FluroTech Ltd. (FLURF)
  • Evome Medical Technologies Inc. (LNDZF)
  • Medical Services International Inc. (MSITF)
  • NantHealth, Inc. (NHIQ)
  • ProSomnus, Inc. (OSA)
  • Phoenix Life Sciences International Limited (PLSI)

Open Achiko AG (ACHKF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.